Cellectar Biosciences: Q2 Earnings Insights

Cellectar Biosciences (NASDAQ:CLRB) reported its Q2 earnings results on Friday, August 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Cellectar Biosciences (NASDAQ:CLRB) reported its Q2 earnings results on Friday, August 5, 2022 at 08:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Cellectar Biosciences missed estimated earnings by 18.45%, reporting an EPS of $-1.22 versus an estimate of $-1.03.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 2.94% drop in the share price the next day.

To track all earnings releases for Cellectar Biosciences visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Recap: Devon Energy Q2 Earnings

Shares of Devon Energy (NYSE:DVN) moved higher in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 433.33% over the past year to $0.60, which beat the estimate of $0.49.

DVN